Similar articles

• Glomerulonephritis and complement regulatory proteins.

  Nangaku M, Johnson RJ, Couser WG. Nangaku M, et al. Exp Nephrol. 1997 Sep-Oct;5(5):345-54. Exp Nephrol. 1997. PMID: 9386969 Review. No abstract available.
• Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.

  Oglesby TJ, White D, Tedja I, Liszewski K, Wright L, Van den Bogarde J, Atkinson JP. Oglesby TJ, et al. Trans Assoc Am Physicians. 1991;104:164-72. Trans Assoc Am Physicians. 1991. PMID: 1726964 No abstract available.
• Mice transgenic for human CD46 and CD55 are protected from human complement attack.

  Mulder LC, Mora M, Ciccopiedi E, Melli C, Nuti S, Marinucci G, Bruzzone P, Lazzeri M, Lorenzini R, Alfani D, et al. Mulder LC, et al. Transplant Proc. 1995 Feb;27(1):333-5. Transplant Proc. 1995. PMID: 7533403 No abstract available.
• [Kidney and complement regulatory factors].

  Matsuo S. Matsuo S. Nihon Rinsho Meneki Gakkai Kaishi. 1995 Dec;18(6):643-6. Nihon Rinsho Meneki Gakkai Kaishi. 1995. PMID: 8963771 Review. Japanese. No abstract available.
• Complement regulatory molecules: application to therapy and transplantation.

  Morgan BP. Morgan BP. Immunol Today. 1995 Jun;16(6):257-9. doi: 10.1016/0167-5699(95)80175-8. Immunol Today. 1995. PMID: 7544975 Review. No abstract available.